Comorbidities, comedications and potential drug–drug interactions among people living with <scp>HIV</scp> in China
Our findings reveal high comorbidity prevalence with significant treatment gaps and frequent potential DDIs among Chinese HIV-positive persons, particularly involving cardiometabolic medications and non-INSTI ART regimens. These results underscore the urgent need for integrated HIV/chronic care models incorporating routine DDI screening to improve clinical outcomes.
Authors
- Haibo Jiang (ORCID: https://orcid.org/0000-0001-5159-2024)
- Leshuang Wu
- Yuecheng Yang (ORCID: https://orcid.org/0000-0002-9716-6773)
- Yidan Zhao
- Lei Han (ORCID: https://orcid.org/0000-0002-7535-7915)
- Qunbo Zhou
- Yingying Ding (ORCID: https://orcid.org/0000-0001-6533-8035)
- Xiaobing Fu (ORCID: https://orcid.org/0000-0002-2465-1700)
- Xin Xin (ORCID: https://orcid.org/0000-0002-7134-886X)
- Yong Zhang (ORCID: https://orcid.org/0000-0003-1436-5951)
- Luqian Shi
Institutions
- Fudan University (CN)
- Guangzhou Center for Disease Control and Prevention (CN)
- Ningbo Center for Disease Control and Prevention (CN)
- Taiwan Centers for Disease Control (TW)
- Guangxi Center for Disease Prevention and Control (CN)
- Guangdong Provincial Center for Disease Control and Prevention (CN)
- Shanghai Municipal Center For Disease Control Prevention (CN)
Publication Details
- Journal
- HIV Medicine
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1111/hiv.70127
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- National Natural Science Foundation of China
- National Science and Technology Major Project